Nanotechnology Now - News Story: "U.S. Clinical Trial of VivaGel(TM)"

Home > News > U.S. Clinical Trial of VivaGel(TM)

October 25th, 2006

U.S. Clinical Trial of VivaGel(TM)

Abstract:
Starpharma Holdings Limited (ASX: SPL) (OTC: SPHRY) today announced that the U.S. site for the clinical trial of SPL7013 gel (VivaGel(TM)) for prevention of genital herpes has opened for recruitment of volunteers.

Source:
prnewswire

Bookmark:

Related News Press

Nanomedicine

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Announcements

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013